Lannett is introducing its generic Lescol XL (fluvastatin sodium extended-release tablets, 80 mg).
The generic is indicated as an adjunct to diet as a treatment for elevated cholesterol levels.
IQVIA data for the year ended May 2021 shows a market of roughly $10 million for the product, with generic market values expected to be lower.
"Although the market potential is modest, we are pleased to offer an affordable Fluvastatin alternative to our customers," Lannett CEO Tim Crew said. "Currently, only one other competitor markets generic Fluvastatin Sodium Extended-release Tablets, 80 mg, in the United States.”